Biotech & Transhumanism Critique

Concerns about nanotechnology, transhumanist agendas, and emerging biotechnology.

Market Overview

Newsletters

2

Monetization Rate

50%

Category avg: 66%

Total Audience

72K— 0.0%

Audience Concentration

100%

Top 5 share of total

30-Day Velocity

0.0%

vs. category avg +19.3%

Monetization Rate vs. All NichesTop 89%

Audience Size vs. All NichesTop 99%

Opportunity Score

Competition Index

0.29x

Below average

Median Subscribers

36K

Per newsletter

Unlock the full Biotech & Transhumanism Critique briefing

Pricing data · Competition analysis · Content gaps · Related niches

Cancel anytime